King Pharmaceuticals KG Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's cash provided by (used in) operating activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's cash provided by (used in) operating activity, including discontinued operation?
- King Pharmaceuticals (KG) reported cash provided by (used in) operating activity, including discontinued operation of -$15.13M in Q1 2026.
- How has King Pharmaceuticals's cash provided by (used in) operating activity, including discontinued operation changed year-over-year?
- King Pharmaceuticals's cash provided by (used in) operating activity, including discontinued operation decreased by 1627.5% year-over-year, from -$876K to -$15.13M.
- What does cash provided by (used in) operating activity, including discontinued operation mean?
- Measures the cash generated from the company's core business operations, excluding financing and investing activities. It reflects the ability of the company to convert revenue into actual cash flow after accounting for changes in working capital.